Stomach cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{MAD}} | {{CMG}}; {{AE}} {{MAD}} | ||
==0verview== | ==0verview== | ||
Laboratory findings in gastric cancer include [[complete blood count]], [[liver function tests]], antigens such as; [[Carcinoembryonic antigen]], [[CA-125|Glycoprotein CA 125]], [[CA19-9|Carbohydrate antigen 19-9]], Cancer antigen 72-4, [[Alpha-fetoprotein]]. | |||
== Stomach cancer laboratory findings == | == Stomach cancer laboratory findings == | ||
Revision as of 23:32, 2 December 2017
|
Stomach cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Stomach cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Stomach cancer laboratory findings |
|
Risk calculators and risk factors for Stomach cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]
0verview
Laboratory findings in gastric cancer include complete blood count, liver function tests, antigens such as; Carcinoembryonic antigen, Glycoprotein CA 125, Carbohydrate antigen 19-9, Cancer antigen 72-4, Alpha-fetoprotein.
Stomach cancer laboratory findings
- A complete blood cell count shows anemia.
- Liver function tests may be disturbed in patients with liver metastasis.
- Carcinoembryonic antigen (CEA) is elevated in 50% of patients. A drop in an elevated level of CEA means response to preoperative therapy but it is not sensitive or specific.
- Glycoprotein CA 125 antigen may be elevated.[1]
- Carbohydrate antigen 19-9 (CA 19-9) is elevated.[2]
- Cancer antigen 72-4 (CA72-4) may be elevated.[3]
- Alpha-fetoprotein (AFP) may be elevated.[4]
References
- ↑ Luo T, Chen W, Wang L, Zhao H (2016). "CA125 is a potential biomarker to predict surgically incurable gastric and cardia cancer: A retrospective study". Medicine (Baltimore). 95 (51): e5297. doi:10.1097/MD.0000000000005297. PMC 5181804. PMID 28002320.
- ↑ Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M (2008). "Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer". Adv Ther. 25 (10): 1075–84. doi:10.1007/s12325-008-0100-4. PMID 18821070.
- ↑ Guadagni F, Roselli M, Cosimelli M, Ferroni P, Spila A, Cavaliere F; et al. (1995). "CA 72-4 serum marker--a new tool in the management of carcinoma patients". Cancer Invest. 13 (2): 227–38. PMID 7874576.
- ↑ Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H; et al. (2002). "Clinicopathologic features of gastric cancers producing alpha-fetoprotein". Dig Surg. 19 (5): 359–65, discussion 365. doi:10.1159/000065838. PMID 12435906.